Discover 2,716 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,716
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase3, Recruiting
Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study
for
Acute Hypoxemic Respiratory Failure
Location: Toronto
Sponsor: Lorenzo delSorbo
Sex: All
Age: 18+
Code: NCT07334379
Phase2, Recruiting
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Halifax, Providence RI, New Haven CT, Quebec,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers
for
Gynecological Cancers
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: Female
Age: 18+
Code: NCT06977126
Phase1, Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
for
Alzheimer Disease, Agitation
Location: Newton MA, Morehead City NC, Virginia Gardens FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT06937229
Phase3, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
for
Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC),
Location: Baltimore MD, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07223047
Phase1, Phase2, Recruiting
Effect of Protocolized Magnesium Replacement on Mortality and Atrial Fibrillation in Critically Ill Patients
for
Critical Illness
Location: Bowmanville, Oshawa, Ajax, Toronto
Sponsor: Scarborough General Hospital
Sex: All
Age: 16+
Code: NCT07173855
Recruiting
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)